ラテラルフローアッセイ市場 – 2030年までの世界予測

本レポートは、ラテラルフローアッセイ市場を製品、用途、技術、サンプルの種類、エンドユーザー、地域の観点から分析しています。また、市場の成長に影響を与える要因（推進要因、制約要因、機会、課題など）を分析するとともに、市場リーダーの競争環境の詳細も提供しています。さらに、ミクロ市場を個々の成長傾向の観点から分析しています。さらに、6つの主要地域（および各地域に属する国）における市場セグメントの収益予測も提供しています。

ラテラルフローアッセイ市場は、予測期間中、2025年の85億1,000万米ドルから2030年には125億2,000万米ドルに拡大し、年平均成長率（CAGR）8.0%で成長すると予測されています。これは、世界的な感染症の蔓延とそれに伴う検査需要の高まり、高齢者人口の急増、家庭用ラテラルフローアッセイ機器の利用増加、そしてPOC検査の需要増加が主な要因であり、これらがこの市場の成長を牽引しています。しかしながら、他の検査方法と比較して精度が一定でない点や、医師と患者が従来の診断法からの移行に消極的であることから、ラテラルフローアッセイ市場の成長は抑制されています。

The lateral flow assays market is estimated to grow from USD 8.51 billion in 2025 to USD 12.52 billion by 2030 at a CAGR of 8.0%, during the forecast period. This is due to the high prevalence of infectious diseases worldwide and the subsequent need for testing, rapid growth in the geriatric population, the rising use of home-based lateral flow assay devices, and the growing demand for POC testing, which are the major factors driving the growth of this market. However, inconsistent accuracy compared to other methods and the reluctance of doctors and patients to shift from traditional diagnostics restrain the growth of the lateral flow assays market.

“The clinical testing segment of the lateral flow assays market, by application, is estimated to hold the largest position during the forecast period.”

The clinical testing segment is the largest application segment in the lateral flow assays market. Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The clinical testing segment accounted for the largest share of the lateral flow assays market in 2024. This trend is projected to continue during the study period. The large share of this application segment can be attributed to the rising prevalence of chronic diseases and infectious diseases worldwide, the growing geriatric population, increasing patient awareness about rapid test options, the growing pressure to reduce healthcare costs, and the increasing demand for patient-centric care.

“The hospitals & clinics segment accounted for the largest market share in the lateral flow assays market.”

Based on end users, the LFA market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment accounted for the largest market share in 2024. Technological advancements, increasing adoption of point-of-care testing, and the growing inclination toward fast and early diagnosis are driving the growth of the hospitals & clinics segment.

“North America segment of the lateral flow assays market, by region, is estimated to account for the largest share during the forecast period.”

The global lateral flow assays market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. North America holds the leading position in this market, driven by advanced healthcare infrastructure, significant healthcare expenditure, and the strong presence of key manufacturers. The increasing aging population, rising prevalence of infectious and chronic diseases, and strong demand for home-use and self-test kits further support market growth in North America. This regional segment is expected to maintain its dominant position throughout the forecast period.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 35%
• By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
• By Region: North America: 50%, Europe: 20%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 3%

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = Greater than USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = Less than USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), QuidelOrtho Corporation (US), Siemens AG (Germany), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), Revvity, Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Merck KGaA (Germany), Surmodics, Inc. (US), and OraSure Technologies Inc. (US).

Research Coverage

This report studies the lateral flow assays market based on product, application, technique, sample type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.

This report provides insights on the following points:

Analysis of key drivers (High prevalence of infectious diseases, Rising geriatric population, Growing use of home-based lateral flow assay devices, and Growing demand for POC testing), restraints (Inconsistent results of lateral flow assay tests), opportunities (Evolving applications of lateral flow assays and Rising demand for lateral flow assays in food & beverage industry), challenges (Limited reimbursements for lateral flow assay products and Difficulties in procuring quality raw materials to develop tests).

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the lateral flow assays market
• Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the lateral flow assays market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the lateral flow assays market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

Table of Contents

1               INTRODUCTION              41

1.1           STUDY OBJECTIVES       41

1.2           MARKET DEFINITION   41

1.2.1        INCLUSIONS & EXCLUSIONS       42

1.3           MARKET SCOPE                43

1.3.1        MARKETS COVERED       43

1.3.2        YEARS CONSIDERED      44

1.4           CURRENCY CONSIDERED            44

1.5           STAKEHOLDERS               44

1.6           SUMMARY OF CHANGES               45

2               RESEARCH METHODOLOGY       46

2.1           RESEARCH DATA              46

2.1.1        SECONDARY DATA          46

2.1.1.1    Key data from secondary sources       47

2.1.2        PRIMARY DATA 48

2.1.2.1    Primary sources    48

2.1.2.2    Key industry insights           49

2.1.2.3    Key data from primary sources           49

2.1.2.4    Breakdown of primary interviews      50

2.2           MARKET SIZE ESTIMATION         51

2.2.1        BOTTOM-UP APPROACH              51

2.2.1.1    Approach 1: Company revenue estimation approach     52

2.2.1.2    Approach 2: Presentations of companies and primary interviews                 52

2.2.1.3    Approach 3: Primary interviews         52

2.2.1.4    Approach 4: Growth Forecast             52

2.2.1.5    CAGR projections                 53

2.2.2        TOP-DOWN APPROACH                53

2.3           MARKET BREAKDOWN & DATA TRIANGULATION                 54

2.4           RESEARCH ASSUMPTIONS           55

2.4.1        STUDY-RELATED ASSUMPTIONS              55

2.4.2        GROWTH RATE ASSUMPTIONS 55

2.5           RISK ASSESSMENT           56

2.6           RESEARCH LIMITATIONS             56

3               EXECUTIVE SUMMARY  57

4               PREMIUM INSIGHTS       62

4.1           LATERAL FLOW ASSAYS MARKET OVERVIEW     62

4.2           ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY   63

4.3           LATERAL FLOW ASSAYS MARKET, BY COUNTRY                 64

4.4           LATERAL FLOW ASSAYS MARKET: REGIONAL MIX                 64

4.5           LATERAL FLOW ASSAYS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS                65

5               MARKET OVERVIEW       66

5.1           INTRODUCTION              66

5.2           MARKET DYNAMICS       66

5.2.1        DRIVERS               66

5.2.1.1    High prevalence of infectious diseases              66

5.2.1.2    Rise in geriatric population 67

5.2.1.3    Growing use of home-based lateral flow assay devices   69

5.2.1.4    Growth in demand for POC testing  69

5.2.2        RESTRAINTS      70

5.2.2.1    Inconsistent results of lateral flow assays          70

5.2.3        OPPORTUNITIES              70

5.2.3.1    Evolving applications of lateral flow assays      70

5.2.3.2    Rise in demand for lateral flow assays in food & beverage industry                 71

5.2.4        CHALLENGES    72

5.2.4.1    Limited reimbursements for lateral flow assay products                 72

5.2.4.2    Difficulties in procuring quality raw materials to develop tests                 72

5.3           TECHNOLOGY ANALYSIS             73

5.3.1        KEY TECHNOLOGIES     73

5.3.1.1    Immunochromatography     73

5.3.2        COMPLEMENTARY TECHNOLOGIES       73

5.3.2.1    Lyophilization (Freeze-drying) Technologies 73

5.3.3        ADJACENT TECHNOLOGIES       73

5.3.3.1    ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)                 73

5.4           PORTER’S FIVE FORCES ANALYSIS           74

5.4.1        BARGAINING POWER OF SUPPLIERS       75

5.4.2        BARGAINING POWER OF BUYERS             75

5.4.3        THREAT OF NEW ENTRANTS      75

5.4.4        THREAT OF SUBSTITUTES          76

5.4.5        INTENSITY OF COMPETITIVE RIVALRY 76

5.5           REGULATORY LANDSCAPE         76

5.5.1        REGULATORY ANALYSIS               76

5.5.1.1    North America      76

5.5.1.2    Europe   77

5.5.1.3    Asia Pacific            77

5.5.1.3.1 India       77

5.5.1.3.2 China      78

5.5.1.3.3 Japan      78

5.5.2        REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  78

5.5.2.1    North America      78

5.5.2.2    Europe   79

5.5.2.3    Asia Pacific            79

5.5.2.4    Latin America       80

5.5.2.5    Rest of the world  80

5.6           PATENT ANALYSIS          80

5.7           TRADE ANALYSIS             83

5.7.1        IMPORT DATA (HS CODE 382200)              83

5.7.2        EXPORT DATA (HS CODE 382200)              83

5.8           PRICING ANALYSIS          84

5.8.1        INDICATIVE AVERAGE SELLING PRICE TREND, BY REGION                85

5.9           KEY CONFERENCES AND EVENTS             86

5.10         KEY STAKEHOLDERS AND BUYING CRITERIA     87

5.10.1      KEY STAKEHOLDERS IN BUYING PROCESS           87

5.10.2      BUYING CRITERIA           88

5.11         UNMET NEEDS/END-USER EXPECTATIONS IN LATERAL FLOW ASSAYS MARKET 88

5.12         VALUE CHAIN ANALYSIS               89

5.13         SUPPLY CHAIN ANALYSIS             90

5.14         IMPACT OF AI ON LATERAL FLOW ASSAYS MARKET                 91

5.14.1      INTRODUCTION              91

5.14.2      MARKET POTENTIAL OF AI IN LATERAL FLOW ASSAYS MARKET               91

5.14.3      AI USE CASES     92

5.14.4      KEY COMPANIES IMPLEMENTING AI      92

5.14.5      FUTURE OF AI IN LATERAL FLOW ASSAYS MARKET                 93

5.15         ECOSYSTEM ANALYSIS  93

5.16         CASE STUDY ANALYSIS 95

5.16.1      QUIDEL LAUNCHED NEW TEST WITH BROADER DETECTION WINDOW  95

5.16.2      ABINGTON OFFERED HIGH-SENSITIVITY TESTS FOR GREATER QUALITY         95

5.16.3      SIEMENS OFFERS HIGH-SENSITIVITY TROPONIN I ASSAY TO RAPIDLY DETECT ACUTE MYOCARDIAL INFARCTION                 95

5.17         ADJACENT MARKETS FOR LATERAL FLOW ASSAYS MARKET               96

5.18         TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            96

5.19         INVESTMENT AND FUNDING SCENARIO               97

5.20         IMPACT OF US TARIFF REGULATION ON LATERAL FLOW ASSAYS MARKET 97

5.20.1      INTRODUCTION              97

5.20.2      KEY TARIFF RATES          98

5.20.3      PRICE IMPACT ANALYSIS             99

5.20.4      KEY IMPACTS ON COUNTRY/REGION    99

5.20.4.1  North America      99

5.20.4.2  Europe   99

5.20.4.3  Asia Pacific            99

5.20.5      IMPACT ON END-USE INDUSTRIES          100

5.20.5.1  Hospitals and Clinics           100

6               LATERAL FLOW ASSAYS MARKET, BY PRODUCT                 101

6.1           INTRODUCTION              102

6.2           KITS & REAGENTS            102

6.2.1        RISE IN DEMAND FOR POC TESTING TO DRIVE MARKET                 102

6.3           READERS             106

6.3.1        DIGITAL/HANDHELD READERS                109

6.3.1.1    Technological evolution and demand for accuracy to drive adoption 109

6.3.2        BENCHTOP READERS    111

6.3.2.1    Lower diagnosis cost per patient to drive segment          111

7               LATERAL FLOW ASSAYS MARKET, BY APPLICATION                 115

7.1           INTRODUCTION              116

7.2           CLINICAL TESTING         116

7.2.1        INFECTIOUS DISEASE TESTING 119

7.2.1.1    Mosquito-borne diseases    122

7.2.1.1.1 Increase in incidence of dengue and introduction of more reliable test kits to drive market       122

7.2.1.2    Influenza                126

7.2.1.2.1 Rise in prevalence of influenza globally to boost market growth, despite lower sensitivity of lateral flow assays 126

7.2.1.3    Sexually transmitted infections           129

7.2.1.3.1 HIV         132

7.2.1.3.1.1              Growing need for early detection and awareness of HIV POC testing to drive market               132

7.2.1.3.2 HPV        135

7.2.1.3.2.1              Rapid HPV diagnostics and real-time PCR, covering broad range of genotypes, coupled with higher incidence of cervical cancer to drive segment   135

7.2.1.3.3 Chlamydia              138

7.2.1.3.3.1              Greater viability of advanced techniques to drive market                 138

7.2.1.3.4 Gonorrhea              141

7.2.1.3.4.1              Rising incidence of gonorrhea and antimicrobial resistance to augment growth             141

7.2.1.3.5 Syphilis  144

7.2.1.3.5.1              Need for early and accessible diagnosis to fuel growth                 144

7.2.1.3.6 Other sexually transmitted infections                147

7.2.1.4    Hepatitis                 150

7.2.1.4.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing                150

7.2.1.5    Tuberculosis          152

7.2.1.5.1 Rise in prevalence and growing focus on early diagnosis and treatment to propel market 152

7.2.1.6    Other infectious diseases    155

7.2.2        CARDIAC MARKER TESTING       157

7.2.2.1    Troponin I & T     160

7.2.2.1.1 Introduction of high-sensitivity troponin assays to support market growth       160

7.2.2.2    CK-MB  163

7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market       163

7.2.2.3    BNP & NT-proBNP             166

7.2.2.3.1 Increase in demand for cardiac biomarker tests to detect heart stress and damage to support growth                166

7.2.2.4    Myoglobin              168

7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth         168

7.2.2.5    D-Dimer                170

7.2.2.5.1 Rising incidence of CVDs to drive market for D-dimer tests                 170

7.2.2.6    Other cardiac marker testing              172

7.2.3        PREGNANCY & FERTILITY TESTING        175

7.2.3.1    Pregnancy testing 178

7.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth    178

7.2.3.2    Fertility testing     181

7.2.3.2.1 Rise in infertility rates to drive demand for POC fertility testing kits          181

7.2.4        CHOLESTEROL/LIPID TESTING 183

7.2.4.1    Lifestyle changes, cardiovascular disorder incidence to drive segment 183

7.2.5        DRUGS-OF-ABUSE TESTING       186

7.2.5.1    Technological advancements and rising focus on workplace drug testing to drive market         186

7.2.6        OTHER CLINICAL TESTS               189

7.3           VETERINARY DIAGNOSTICS       192

7.3.1        INFECTIOUS DISEASE OUTBREAKS AND TESTS AVAILABLE FOR DIFFERENT SPECIES TO DRIVE FRAGMENTED MARKET               192

7.4           FOOD SAFETY & ENVIRONMENT TESTING           194

7.4.1        HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS TO CLEAR FOODS FOR MARKET AVAILABILITY   194

7.5           DRUG DEVELOPMENT & QUALITY TESTING       196

7.5.1        GREATER FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH    196

8               LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE                 200

8.1           INTRODUCTION              201

8.2           SANDWICH ASSAYS         201

8.2.1        WIDE RANGE OF APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH              201

8.3           COMPETITIVE ASSAYS  204

8.3.1        REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH   204

8.4           MULTIPLEX DETECTION ASSAYS              206

8.4.1        HIGHER ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO FUEL MARKET 206

9               LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE                 210

9.1           INTRODUCTION              211

9.2           BLOOD SAMPLES             211

9.2.1        SIGNIFICANT USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET         211

9.3           URINE SAMPLES               214

9.3.1        GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET     214

9.4           SALIVA SAMPLES              216

9.4.1        EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION                 216

9.5           OTHER SAMPLES              218

10            LATERAL FLOW ASSAYS MARKET, BY END USER                 221

10.1         INTRODUCTION              222

10.2         HOSPITALS & CLINICS   222

10.2.1      HIGH DEMAND FOR DIAGNOSTICS ACROSS LARGE POOLS OF PATIENTS IN HOSPITALS TO DRIVE MARKET                 222

10.3         HOME CARE SETTINGS 225

10.3.1      GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET             225

10.4         DIAGNOSTIC LABORATORIES    227

10.4.1      LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING                 227

10.5         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 230

10.5.1      INCREASE IN FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS 230

10.6         OTHER END USERS         232

11            LATERAL FLOW ASSAYS MARKET, BY REGION    236

11.1         INTRODUCTION              237

11.2         NORTH AMERICA             238

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 238

11.2.2      US           244

11.2.2.1  Large patient base to drive market growth       244

11.2.3      CANADA               249

11.2.3.1  Availability of research funding and implementation of favorable government initiatives to drive market              249

11.3         EUROPE               254

11.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      254

11.3.2      GERMANY           259

11.3.2.1  Well-developed healthcare system and rise in geriatric population to fuel growth        259

11.3.3      UK          264

11.3.3.1  Growth in incidence of chronic conditions to propel market growth    264

11.3.4      FRANCE                269

11.3.4.1  High prevalence of age-related chronic diseases and infectious diseases to drive market      269

11.3.5      ITALY    274

11.3.5.1  Growth in initiatives toward decentralization of medical services to support market growth    274

11.3.6      SPAIN    278

11.3.6.1  Aging population and strong healthcare infrastructure to drive market    278

11.3.7      REST OF EUROPE             283

11.4         ASIA PACIFIC     288

11.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 288

11.4.2      JAPAN   294

11.4.2.1  Growing elderly population and well-developed healthcare system to drive market         294

11.4.3      CHINA  299

11.4.3.1  Modernized healthcare system to drive market                299

11.4.4      INDIA    304

11.4.4.1  Growth in healthcare concerns and rise in income levels to propel market growth, despite lack of reimbursement and insurance coverage for lateral flow assay products  304

11.4.5      AUSTRALIA         309

11.4.5.1  Rise in prevalence of infectious disease and healthcare expenditure to support growth           309

11.4.6      SOUTH KOREA  314

11.4.6.1  Growth in healthcare infrastructure to drive market      314

11.4.7      REST OF ASIA PACIFIC   319

11.5         LATIN AMERICA                324

11.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 324

11.5.2      BRAZIL 329

11.5.2.1  High private healthcare expenditure and rise in geriatric population to drive market 329

11.5.3      MEXICO                334

11.5.3.1  Increase in demand for advanced medical equipment to drive market    334

11.5.4      ARGENTINA       339

11.5.4.1  Availability of health insurance to favor market growth 339

11.5.5      REST OF LATIN AMERICA             343

11.6         MIDDLE EAST & AFRICA                348

11.7         GCC COUNTRIES              353

11.7.1      RISE IN DEMAND FOR RAPID AND COST-EFFECTIVE DIAGNOSTICS

TO DRIVE MARKET         353

12            COMPETITIVE LANDSCAPE         359

12.1         INTRODUCTION              359

12.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            359

12.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL FLOW ASSAYS MARKET        360

12.3         REVENUE ANALYSIS, 2020-2024   361

12.4         MARKET SHARE ANALYSIS, 2024                 362

12.5         COMPANY VALUATION AND FINANCIAL METRICS                 364

12.6         BRAND/PRODUCT COMPARISON             365

12.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 366

12.7.1      STARS   366

12.7.2      EMERGING LEADERS     366

12.7.3      PERVASIVE PLAYERS      366

12.7.4      PARTICIPANTS 366

12.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         368

12.7.5.1  Company footprint               368

12.7.5.2  Regional Footprint                369

12.7.5.3  Product Footprint 370

12.7.5.4  Technique Footprint            371

12.7.5.5  Application Footprint           372

12.7.5.6  Sample type Footprint         373

12.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        373

12.8.1      PROGRESSIVE COMPANIES         373

12.8.2      RESPONSIVE COMPANIES            374

12.8.3      DYNAMIC COMPANIES  374

12.8.4      STARTING BLOCKS         374

12.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 375

12.8.5.1  Detailed list of key startup/SME players          375

12.8.5.2  Competitive benchmarking of key startups/SMEs          375

12.9         COMPETITIVE SCENARIO             376

12.9.1      PRODUCT LAUNCHES   376

12.9.2      DEALS  376

12.9.3      EXPANSIONS     377

13            COMPANY PROFILES      378

13.1         KEY PLAYERS     378

13.1.1      ABBOTT LABORATORIES             378

13.1.1.1  Business overview 378

13.1.1.2  Products offered   379

13.1.1.3  Recent developments           383

13.1.1.3.1                Product launches & approvals            383

13.1.1.4  MnM view              383

13.1.1.4.1                Right to win           383

13.1.1.4.2                Strategic choices   383

13.1.1.4.3                Weaknesses and competitive threats 383

13.1.2      F. HOFFMANN-LA ROCHE LTD. 384

13.1.2.1  Business overview 384

13.1.2.2  Products offered   385

13.1.2.3  MnM view              386

13.1.2.3.1                Right to win           386

13.1.2.3.2                Strategic choices   386

13.1.2.3.3                Weaknesses and competitive threats 386

13.1.3      DANAHER CORPORATION           387

13.1.3.1  Business overview 387

13.1.3.2  Products offered   388

13.1.3.3  MnM view              389

13.1.3.3.1                Right to win           389

13.1.3.3.2                Strategic choices   389

13.1.3.3.3                Weaknesses and competitive threats 389

13.1.4      QUIDELORTHOORTHO CORPORATION                390

13.1.4.1  Business overview 390

13.1.4.2  Products offered   391

13.1.4.3  Recent developments           392

13.1.4.3.1                Deals      392

13.1.5      SIEMENS AG       393

13.1.5.1  Business overview 393

13.1.5.2  Products offered   395

13.1.6      BECTON, DICKINSON AND COMPANY   396

13.1.6.1  Business overview 396

13.1.6.2  Products offered   398

13.1.7      BIOMÉRIEUX SA                399

13.1.7.1  Business overview 399

13.1.7.2  Products offered   400

13.1.7.3  Recent developments           401

13.1.7.3.1                Deals      401

13.1.8      THERMO FISHER SCIENTIFIC INC.            402

13.1.8.1  Business overview 402

13.1.8.2  Products offered   403

13.1.9      REVVITY, INC.   405

13.1.9.1  Business overview 405

13.1.9.2  Products offered   406

13.1.10   QIAGEN N.V.      407

13.1.10.1                 Business overview 407

13.1.10.2                 Products offered   408

13.1.11   MERCK KGAA    409

13.1.11.1                 Business overview 409

13.1.11.2                 Products offered   410

13.1.11.3                 Recent developments           410

13.1.11.3.1             Expansions             410

13.1.12   HOLOGIC, INC. 411

13.1.12.1                 Business overview 411

13.1.12.2                 Products offered   412

13.1.12.3                 Recent developments           413

13.1.12.3.1             Deals      413

13.1.13   SURMODICS, INC.            414

13.1.13.1                 Business overview 414

13.1.13.2                 Products offered   416

13.1.13.3                 Recent developments           416

13.1.13.3.1             Deals      416

13.1.14   ORASURE TECHNOLOGIES          417

13.1.14.1                 Business overview 417

13.1.14.2                 Products offered   418

13.2         OTHER PLAYERS              419

13.2.1      CHEMBIO DIAGNOSTICS INC.    419

13.2.2      DCN DIAGNOSTICS        420

13.2.3      POLYSCIENCES INC.       421

13.2.4      ABINGDON HEALTH       422

13.2.5      ORANOXIS INC. 423

13.2.6      AESKU.GROUP GMBH    424

13.2.7      BIO GROUP MEDICAL SYSTEM S.R.L        425

13.2.8      PHARMACT GMBH          426

13.2.9      XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD. 427

13.2.10   BIOPANDA REAGENTS LTD         428

13.2.11   ARTRON LABORATORIES INC.   429

14            APPENDIX           430

14.1         DISCUSSION GUIDE        430

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                435

14.3         CUSTOMIZATION OPTIONS        437

14.4         RELATED REPORTS         437

14.5         AUTHOR DETAILS           438

LIST OF TABLES

TABLE 1                LATERAL FLOW ASSAYS MARKET: INCLUSIONS & EXCLUSIONS 42

TABLE 2                KEY DATA FROM PRIMARY SOURCES     49

TABLE 3                LATERAL FLOW ASSAYS MARKET: RISK ASSESSMENT     56

TABLE 4                REAL INCIDENCE OF HIV, 2023 (MILLION PEOPLE)              67

TABLE 5                POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023        68

TABLE 6                LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS                 71

TABLE 7                LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 75

TABLE 8                NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  78

TABLE 9                EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  79

TABLE 10              ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  79

TABLE 11             LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  80

TABLE 12              ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  80

TABLE 13              LATERAL FLOW ASSAYS MARKET: INNOVATIONS AND

PATENT REGISTRATIONS, 2023–2025       82

TABLE 14              IMPORT DATA (HS CODE 382200), BY COUNTRY, 2020–2024 (USD MILLION)            83

TABLE 15              EXPORT DATA (HS CODE 382200), BY COUNTRY, 2020–2024 (USD MILLION)            83

TABLE 16              AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS),

BY COMPANY, 2023–2025 (USD) 84

TABLE 17              AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS),

BY APPLICATION, 2023–2025 (USD)          84

TABLE 18              INDICATIVE AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS,

BY REGION, 2023 VS. 2024              85

TABLE 19              LATERAL FLOW ASSAYS MARKET: KEY CONFERENCES AND EVENTS,

JUNE 2025–DECEMBER 2026          86

TABLE 20              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR

TOP THREE APPLICATIONS        87

TABLE 21              KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 88

TABLE 22              UNMET NEEDS/END-USER EXPECTATIONS IN LATERAL FLOW ASSAYS MARKET              88

TABLE 23              LATERAL FLOW ASSAYS MARKET: ROLE OF COMPANIES IN ECOSYSTEM       94

TABLE 24              US ADJUSTED RECIPROCAL TARIFF RATES                 98

TABLE 25              LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            102

TABLE 26              LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS,

BY REGION, 2023–2030 (USD MILLION)   103

TABLE 27              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               103

TABLE 28              EUROPE: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               103

TABLE 29              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               104

TABLE 30              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR KITS & REAGENTS,

BY COUNTRY, 2023–2030 (USD MILLION)               104

TABLE 31              INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS:

WITH AND WITHOUT ANALYZERS           105

TABLE 32              LATERAL FLOW READERS OFFERED, BY COMPANY           106

TABLE 33             LATERAL FLOW ASSAYS MARKET, FOR READERS, BY TYPE,

2023–2030 (USD MILLION)            107

TABLE 34              LATERAL FLOW ASSAYS MARKET FOR READERS, BY REGION,

2023–2030 (USD MILLION)            107

TABLE 35              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR READERS,

BY COUNTRY, 2023–2030 (USD MILLION)               107

TABLE 36              EUROPE: LATERAL FLOW ASSAYS MARKET FOR READERS,

BY COUNTRY, 2023–2030 (USD MILLION)               108

TABLE 37              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR READERS,

BY COUNTRY, 2023–2030 (USD MILLION)               108

TABLE 38              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR READERS,

BY COUNTRY, 2023–2030 (USD MILLION)               109

TABLE 39              LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS,

BY REGION, 2023–2030 (USD MILLION)   110

TABLE 40              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION)            110

TABLE 41              EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS,

BY COUNTRY, 2023–2030 (USD MILLION)               110

TABLE 42              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION) 111

TABLE 43              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIGITAL/HANDHELD READERS, BY COUNTRY, 2023–2030 (USD MILLION)            111

TABLE 44              LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS,

BY REGION, 2023–2030 (USD MILLION)   112

TABLE 45              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS,

BY COUNTRY, 2023–2030 (USD MILLION)               112

TABLE 46              EUROPE: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS,

BY COUNTRY, 2023–2030 (USD MILLION)               113

TABLE 47              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS,

BY COUNTRY, 2023–2030 (USD MILLION)               113

TABLE 48              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BENCHTOP READERS,

BY COUNTRY, 2023–2030 (USD MILLION)               114

TABLE 49              LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              116

TABLE 50              LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         117

TABLE 51              LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY REGION, 2023–2030 (USD MILLION)   117

TABLE 52              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               118

TABLE 53              EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               118

TABLE 54              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               119

TABLE 55              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               119

TABLE 56              LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       120

TABLE 57              LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY REGION, 2023–2030 (USD MILLION)   120

TABLE 58              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)            121

TABLE 59              EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               121

TABLE 60              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 122

TABLE 61              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)            122

TABLE 62              MAJOR PRODUCTS: DENGUE TESTING 123

TABLE 63              LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES,

BY REGION, 2023–2030 (USD MILLION)   124

TABLE 64              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)            124

TABLE 65              EUROPE: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES,

BY COUNTRY, 2023–2030 (USD MILLION)               125

TABLE 66              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 125

TABLE 67              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)            126

TABLE 68              LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY REGION,

2023–2030 (USD MILLION)            127

TABLE 69              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA,

BY COUNTRY, 2023–2030 (USD MILLION)               127

TABLE 70              EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA,

BY COUNTRY, 2023–2030 (USD MILLION)               128

TABLE 71              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA,

BY COUNTRY, 2023–2030 (USD MILLION)               128

TABLE 72              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFLUENZA,

BY COUNTRY, 2023–2030 (USD MILLION)               129

TABLE 73              LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,

BY TYPE, 2023–2030 (USD MILLION)         130

TABLE 74              LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,

BY REGION, 2023–2030 (USD MILLION)   130

TABLE 75              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)     131

TABLE 76              EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)       131

TABLE 77              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)            132

TABLE 78              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)     132

TABLE 79              LATERAL FLOW ASSAYS MARKET FOR HIV, BY REGION, 2023–2030 (USD MILLION)          133

TABLE 80              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV,

BY COUNTRY, 2023–2030 (USD MILLION)               133

TABLE 81              EUROPE: LATERAL FLOW ASSAYS MARKET FOR HIV,

BY COUNTRY, 2023–2030 (USD MILLION)               134

TABLE 82              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HIV,

BY COUNTRY, 2023–2030 (USD MILLION)               134

TABLE 83              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HIV,

BY COUNTRY, 2023–2030 (USD MILLION)               135

TABLE 84              LATERAL FLOW ASSAYS MARKET FOR HPV, BY REGION,

2023–2030 (USD MILLION)            136

TABLE 85              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV,

BY COUNTRY, 2023–2030 (USD MILLION)               136

TABLE 86              EUROPE: LATERAL FLOW ASSAYS MARKET FOR HPV,

BY COUNTRY, 2023–2030 (USD MILLION)               137

TABLE 87              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HPV,

BY COUNTRY, 2023–2030 (USD MILLION)               137

TABLE 88              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HPV,

BY COUNTRY, 2023–2030 (USD MILLION)               138

TABLE 89              KEY CHLAMYDIA TESTING PRODUCTS AVAILABLE WORLDWIDE             139

TABLE 90              LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA,

BY REGION, 2023–2030 (USD MILLION)   139

TABLE 91              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               139

TABLE 92              EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               140

TABLE 93              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               140

TABLE 94              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA,

BY COUNTRY, 2023–2030 (USD MILLION)               141

TABLE 95              LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY REGION,

2023–2030 (USD MILLION)            142

TABLE 96              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA,

BY COUNTRY, 2023–2030 (USD MILLION)               142

TABLE 97              EUROPE: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA,

BY COUNTRY, 2023–2030 (USD MILLION)               143

TABLE 98              ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA,

BY COUNTRY, 2023–2030 (USD MILLION)               143

TABLE 99              LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR GONORRHEA,

BY COUNTRY, 2023–2030 (USD MILLION)               144

TABLE 100            LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY REGION,

2023–2030 (USD MILLION)            145

TABLE 101            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS,

BY COUNTRY, 2023–2030 (USD MILLION)               145

TABLE 102            EUROPE: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS,

BY COUNTRY, 2023–2030 (USD MILLION)               146

TABLE 103            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS,

BY COUNTRY, 2023–2030 (USD MILLION)               146

TABLE 104            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SYPHILIS,

BY COUNTRY, 2023–2030 (USD MILLION)               147

TABLE 105            LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2023–2030 (USD MILLION) 148

TABLE 106            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)               148

TABLE 107            EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)            149

TABLE 108            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)     149

TABLE 109            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)               150

TABLE 110            LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY REGION,

2023–2030 (USD MILLION)            151

TABLE 111            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS,

BY COUNTRY, 2023–2030 (USD MILLION)               151

TABLE 112            EUROPE: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS,

BY COUNTRY, 2023–2030 (USD MILLION)               151

TABLE 113            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS,

BY COUNTRY, 2023–2030 (USD MILLION)               152

TABLE 114            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HEPATITIS,

BY COUNTRY, 2023–2030 (USD MILLION)               152

TABLE 115            GLOBAL NUMBER OF NEWLY DIAGNOSED TB CASES, 2023–2030 (MILLION)       153

TABLE 116            LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS,

BY REGION, 2023–2030 (USD MILLION)   153

TABLE 117            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS,

BY COUNTRY, 2023–2030 (USD MILLION)               153

TABLE 118            EUROPE: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS,

BY COUNTRY, 2023–2030 (USD MILLION)               154

TABLE 119            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS,

BY COUNTRY, 2023–2030 (USD MILLION)               154

TABLE 120            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS,

BY COUNTRY, 2023–2030 (USD MILLION)               155

TABLE 121            LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES,

BY REGION, 2023–2030 (USD MILLION)   155

TABLE 122            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)            156

TABLE 123            EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES,

BY COUNTRY, 2023–2030 (USD MILLION)               156

TABLE 124            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 157

TABLE 125            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)            157

TABLE 126            LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         158

TABLE 127            LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY REGION, 2023–2030 (USD MILLION)   159

TABLE 128            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)       159

TABLE 129            EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               159

TABLE 130            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)            160

TABLE 131            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)       160

TABLE 132            LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING,

BY REGION, 2023–2030 (USD MILLION)   161

TABLE 133            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION)       161

TABLE 134            EUROPE: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               162

TABLE 135            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               162

TABLE 136            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2023–2030 (USD MILLION)       163

TABLE 137            LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY REGION,

2023–2030 (USD MILLION)            164

TABLE 138            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               164

TABLE 139            EUROPE: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               164

TABLE 140            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               165

TABLE 141            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               165

TABLE 142            LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING,

BY REGION, 2023–2030 (USD MILLION)   166

TABLE 143            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)       166

TABLE 144            EUROPE: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               167

TABLE 145            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)            167

TABLE 146            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2023–2030 (USD MILLION)       168

TABLE 147            LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING,

BY REGION, 2023–2030 (USD MILLION)   169

TABLE 148            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               169

TABLE 149            EUROPE: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               169

TABLE 150            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               170

TABLE 151            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               170

TABLE 152            LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING,

BY REGION, 2023–2030 (USD MILLION)   171

TABLE 153            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               171

TABLE 154            EUROPE: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               171

TABLE 155            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               172

TABLE 156            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               172

TABLE 157            LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING,

BY REGION, 2023–2030 (USD MILLION)   173

TABLE 158            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)     173

TABLE 159            EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 174

TABLE 160            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)       174

TABLE 161            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTING, BY COUNTRY, 2023–2030 (USD MILLION)     175

TABLE 162            LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,

BY TYPE, 2023–2030 (USD MILLION)         176

TABLE 163            LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,

BY REGION, 2023–2030 (USD MILLION)   176

TABLE 164            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)                 176

TABLE 165            EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 177

TABLE 166            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)                 177

TABLE 167            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)                 178

TABLE 168            KEY PREGNANCY TESTING PRODUCTS AVAILABLE WORLDWIDE             179

TABLE 169            LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING,

BY REGION, 2023–2030 (USD MILLION)   179

TABLE 170            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               180

TABLE 171            EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               180

TABLE 172            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               180

TABLE 173            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               181

TABLE 174            LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING,

BY REGION, 2023–2030 (USD MILLION)   182

TABLE 175            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               182

TABLE 176            EUROPE: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               182

TABLE 177            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               183

TABLE 178            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               183

TABLE 179            KEY CHOLESTEROL TESTING PRODUCTS AVAILABLE WORLDWIDE             184

TABLE 180            LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING,

BY REGION, 2023–2030 (USD MILLION)   184

TABLE 181            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION)            185

TABLE 182            EUROPE: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               185

TABLE 183            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 186

TABLE 184            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2023–2030 (USD MILLION)            186

TABLE 185            LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING,

BY REGION, 2023–2030 (USD MILLION)   187

TABLE 186            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)       187

TABLE 187            EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               188

TABLE 188            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING,

BY COUNTRY, 2023–2030 (USD MILLION)               188

TABLE 189            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG-OF-ABUSE TESTING, BY COUNTRY, 2023–2030 (USD MILLION)       189

TABLE 190            LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS,

BY REGION, 2023–2030 (USD MILLION)   190

TABLE 191            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2023–2030 (USD MILLION) 190

TABLE 192            EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS,

BY COUNTRY, 2023–2030 (USD MILLION)               190

TABLE 193            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS,

BY COUNTRY, 2023–2030 (USD MILLION)               191

TABLE 194            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS,

BY COUNTRY, 2023–2030 (USD MILLION)               191

TABLE 195            LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS,

BY REGION, 2023–2030 (USD MILLION)   192

TABLE 196            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)       193

TABLE 197            EUROPE: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS,

BY COUNTRY, 2023–2030 (USD MILLION)               193

TABLE 198            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS,

BY COUNTRY, 2023–2030 (USD MILLION)               193

TABLE 199            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)       194

TABLE 200            LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING,

BY REGION, 2023–2030 (USD MILLION)   195

TABLE 201            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD &

ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION)            195

TABLE 202            EUROPE: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 195

TABLE 203            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION) 196

TABLE 204            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR FOOD & ENVIRONMENT TESTING, BY COUNTRY, 2023–2030 (USD MILLION)            196

TABLE 205            LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY REGION, 2023–2030 (USD MILLION) 197

TABLE 206            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)     197

TABLE 207            EUROPE: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT &

QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)                 198

TABLE 208            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)            198

TABLE 209            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2023–2030 (USD MILLION)     199

TABLE 210            LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 201

TABLE 211            LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS,

BY REGION, 2023–2030 (USD MILLION)   202

TABLE 212            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               202

TABLE 213            EUROPE: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               203

TABLE 214            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               203

TABLE 215            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SANDWICH ASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               204

TABLE 216            LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS,

BY REGION, 2023–2030 (USD MILLION)   205

TABLE 217            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               205

TABLE 218            EUROPE: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               205

TABLE 219            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               206

TABLE 220            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR COMPETITIVE ASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               206

TABLE 221            LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS,

BY REGION, 2023–2030 (USD MILLION)   207

TABLE 222            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)            207

TABLE 223            EUROPE: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS,

BY COUNTRY, 2023–2030 (USD MILLION)               208

TABLE 224            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION) 208

TABLE 225            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)            209

TABLE 226            LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2023–2030 (USD MILLION)                211

TABLE 227            LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES,

BY REGION, 2023–2030 (USD MILLION)   212

TABLE 228            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               212

TABLE 229            EUROPE: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               212

TABLE 230            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               213

TABLE 231            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               213

TABLE 232            LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES,

BY REGION, 2023–2030 (USD MILLION)   214

TABLE 233            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               214

TABLE 234            EUROPE: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               215

TABLE 235            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               215

TABLE 236            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               216

TABLE 237            LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES,

BY REGION, 2023–2030 (USD MILLION)   216

TABLE 238            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               217

TABLE 239            EUROPE: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               217

TABLE 240            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               217

TABLE 241            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               218

TABLE 242            LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES,

BY REGION, 2023–2030 (USD MILLION)   219

TABLE 243            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               219

TABLE 244            EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               219

TABLE 245            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               220

TABLE 246            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES,

BY COUNTRY, 2023–2030 (USD MILLION)               220

TABLE 247            LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)            222

TABLE 248            LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS,

BY REGION, 2023–2030 (USD MILLION)   223

TABLE 249            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY, 2023–2030 (USD MILLION)               224

TABLE 250            EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY, 2023–2030 (USD MILLION)               224

TABLE 251            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY, 2023–2030 (USD MILLION)               224

TABLE 252            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS,

BY COUNTRY, 2023–2030 (USD MILLION)               225

TABLE 253            LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS,

BY REGION, 2023–2030 (USD MILLION)   226

TABLE 254            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2023–2030 (USD MILLION)               226

TABLE 255            EUROPE: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2023–2030 (USD MILLION)               226

TABLE 256            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2023–2030 (USD MILLION)               227

TABLE 257            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2023–2030 (USD MILLION)               227

TABLE 258            LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES,

BY REGION, 2023–2030 (USD MILLION)   228

TABLE 259            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            228

TABLE 260            EUROPE: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES,

BY COUNTRY, 2023–2030 (USD MILLION)               229

TABLE 261            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 229

TABLE 262            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)            230

TABLE 263            LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)          231

TABLE 264            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)   231

TABLE 265            EUROPE: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     231

TABLE 266            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)     232

TABLE 267            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)   232

TABLE 268            LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS,

BY REGION, 2023–2030 (USD MILLION)   233

TABLE 269            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               233

TABLE 270            EUROPE: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               234

TABLE 271            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               234

TABLE 272            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               235

TABLE 273            LATERAL FLOW ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)            237

TABLE 274            NORTH AMERICA: MACROECONOMIC INDICATORS      238

TABLE 275            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               239

TABLE 276            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               240

TABLE 277            NORTH AMERICA: LATERAL FLOW READERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         240

TABLE 278            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       240

TABLE 279            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         241

TABLE 280            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)            241

TABLE 281            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)            242

TABLE 282            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 242

TABLE 283            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 243

TABLE 284            NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          243

TABLE 285            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       243

TABLE 286            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            244

TABLE 287            US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     245

TABLE 288          US: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)            245

TABLE 289            US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            245

TABLE 290            US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         246

TABLE 291            US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       246

TABLE 292            US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 247

TABLE 293            US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         247

TABLE 294            US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,

BY TYPE, 2023–2030 (USD MILLION)         248

TABLE 295            US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          248

TABLE 296            US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       248

TABLE 297            US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)                249

TABLE 298            CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            250

TABLE 299            CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)         250

TABLE 300            CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            250

TABLE 301            CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         251

TABLE 302            CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       251

TABLE 303            CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 252

TABLE 304            CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         252

TABLE 305            CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 253

TABLE 306            CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          253

TABLE 307            CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       253

TABLE 308            CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            254

TABLE 309            EUROPE: MACROECONOMIC INDICATORS                 254

TABLE 310            EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            255

TABLE 311            EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            255

TABLE 312            EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                255

TABLE 313            EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            256

TABLE 314            EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         256

TABLE 315            EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       257

TABLE 316            EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 257

TABLE 317            EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         258

TABLE 318            EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)            258

TABLE 319            EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          258

TABLE 320            EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       259

TABLE 321            EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            259

TABLE 322            GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            260

TABLE 323            GERMANY: LATERAL FLOW READERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            260

TABLE 324            GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            261

TABLE 325            GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         261

TABLE 326            GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)       262

TABLE 327            GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 262

TABLE 328            GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         263

TABLE 329            GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY

& FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 263

TABLE 330            GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          263

TABLE 331            GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       264

TABLE 332            GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            264

TABLE 333            UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     265

TABLE 334            UK: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                265

TABLE 335            UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            265

TABLE 336            UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         266

TABLE 337            UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       266

TABLE 338            UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 267

TABLE 339            UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         267

TABLE 340            UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,

BY TYPE, 2023–2030 (USD MILLION)         268

TABLE 341            UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          268

TABLE 342            UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       268

TABLE 343            UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)                269

TABLE 344            FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            270

TABLE 345            FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                270

TABLE 346            FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            270

TABLE 347            FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         271

TABLE 348            FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       271

TABLE 349            FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 272

TABLE 350            FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         272

TABLE 351            FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)            273

TABLE 352            FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          273

TABLE 353            FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       273

TABLE 354            FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            274

TABLE 355            ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     274

TABLE 356            ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                275

TABLE 357            ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            275

TABLE 358            ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         275

TABLE 359            ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       276

TABLE 360            ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 276

TABLE 361            ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         277

TABLE 362            ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,

BY TYPE, 2023–2030 (USD MILLION)         277

TABLE 363            ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          277

TABLE 364            ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       278

TABLE 365            ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            278

TABLE 366            SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            279

TABLE 367            SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                279

TABLE 368            SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            279

TABLE 369            SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         280

TABLE 370            SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       280

TABLE 371            SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 281

TABLE 372            SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         281

TABLE 373            SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)            282

TABLE 374            SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          282

TABLE 375            SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       282

TABLE 376            SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            283

TABLE 377            REST OF EUROPE: LATERAL FLOW ASSAYS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               283

TABLE 378            REST OF EUROPE: LATERAL FLOW READERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         284

TABLE 379            REST OF EUROPE: LATERAL FLOW ASSAYS MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       284

TABLE 380            REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         284

TABLE 381            REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)            285

TABLE 382            REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)            285

TABLE 383            REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 286

TABLE 384            REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 286

TABLE 385            REST OF EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          286

TABLE 386            REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       287

TABLE 387            REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            287

TABLE 388            ASIA PACIFIC: KEY MACROECONOMIC INDICATORS      288

TABLE 389            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            290

TABLE 390            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            290

TABLE 391            ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)     290

TABLE 392            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)       291

TABLE 393            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)                 291

TABLE 394            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)       292

TABLE 395            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 292

TABLE 396            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)            293

TABLE 397            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 293

TABLE 398            ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          293

TABLE 399            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       294

TABLE 400            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            294

TABLE 401            JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            295

TABLE 402            JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                295

TABLE 403            JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            296

TABLE 404            JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         296

TABLE 405            JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       297

TABLE 406            JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 297

TABLE 407            JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         298

TABLE 408            JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)            298

TABLE 409            JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          298

TABLE 410            JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       299

TABLE 411            JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            299

TABLE 412            CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            300

TABLE 413            CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                300

TABLE 414            CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            301

TABLE 415            CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         301

TABLE 416            CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       302

TABLE 417            CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 302

TABLE 418            CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         303

TABLE 419            CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)            303

TABLE 420            CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          303

TABLE 421            CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       304

TABLE 422            CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            304

TABLE 423            INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     305

TABLE 424            INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                305

TABLE 425            INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            305

TABLE 426            INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         306

TABLE 427            INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       306

TABLE 428            INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 307

TABLE 429            INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         307

TABLE 430            INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,

BY TYPE, 2023–2030 (USD MILLION)         308

TABLE 431            INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          308

TABLE 432            INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       308

TABLE 433            INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            309

TABLE 434            AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            310

TABLE 435            AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            310

TABLE 436            AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            310

TABLE 437            AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         311

TABLE 438            AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)       311

TABLE 439            AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 312

TABLE 440            AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         312

TABLE 441            AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 313

TABLE 442            AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          313

TABLE 443            AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       313

TABLE 444            AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            314

TABLE 445            SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            315

TABLE 446            SOUTH KOREA: LATERAL FLOW READERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            315

TABLE 447            SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            315

TABLE 448            SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         316

TABLE 449            SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)            316

TABLE 450            SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)            317

TABLE 451            SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 317

TABLE 452            SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 318

TABLE 453            SOUTH KOREA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          318

TABLE 454            SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       318

TABLE 455            SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            319

TABLE 456            REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               320

TABLE 457            REST OF ASIA PACIFIC: LATERAL FLOW READERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         320

TABLE 458            REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       320

TABLE 459            REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)            321

TABLE 460            REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)            321

TABLE 461            REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)            322

TABLE 462            REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 322

TABLE 463            REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY

& FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 323

TABLE 464            REST OF ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          323

TABLE 465            REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION) 323

TABLE 466            REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET,

BY END USER, 2023–2030 (USD MILLION)               324

TABLE 467            LATIN AMERICA: KEY MACROECONOMIC INDICATORS      324

TABLE 468            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            325

TABLE 469            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            325

TABLE 470            LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            325

TABLE 471            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            326

TABLE 472            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         326

TABLE 473            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)            327

TABLE 474            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)            327

TABLE 475            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 328

TABLE 476            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 328

TABLE 477            LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          328

TABLE 478            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       329

TABLE 479            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET,

BY END USER, 2023–2030 (USD MILLION)               329

TABLE 480            BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            330

TABLE 481            BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                330

TABLE 482            BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            330

TABLE 483            BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         331

TABLE 484            BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       331

TABLE 485            BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 332

TABLE 486            BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         332

TABLE 487            BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)            333

TABLE 488            BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          333

TABLE 489            BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       333

TABLE 490            BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            334

TABLE 491            MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            335

TABLE 492            MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)                335

TABLE 493            MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            335

TABLE 494            MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         336

TABLE 495            MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2023–2030 (USD MILLION)       336

TABLE 496            MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 337

TABLE 497            MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         337

TABLE 498            MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)            338

TABLE 499            MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          338

TABLE 500            MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       338

TABLE 501            MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            339

TABLE 502            ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            339

TABLE 503            ARGENTINA: LATERAL FLOW READERS MARKET, BY TYPE,

2023–2030 (USD MILLION)            340

TABLE 504            ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            340

TABLE 505            ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         340

TABLE 506            ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)       341

TABLE 507            ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION) 341

TABLE 508            ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2023–2030 (USD MILLION)         342

TABLE 509            ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 342

TABLE 510            ARGENTINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          342

TABLE 511            ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       343

TABLE 512            ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY END USER,

2023–2030 (USD MILLION)            343

TABLE 513            REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               344

TABLE 514            REST OF LATIN AMERICA: LATERAL FLOW READERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         344

TABLE 515            REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       344

TABLE 516            REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION) 345

TABLE 517            REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)             345

TABLE 518            REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)         346

TABLE 519            REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)            346

TABLE 520            REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY

& FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 347

TABLE 521            REST OF LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          347

TABLE 522            REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION)            347

TABLE 523            REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET,

BY END USER, 2023–2030 (USD MILLION)               348

TABLE 524            MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS              349

TABLE 525            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               349

TABLE 526            MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         349

TABLE 527            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       350

TABLE 528            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET

FOR CLINICAL TESTING, BY TYPE, 2023–2030 (USD MILLION)                 350

TABLE 529            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)             351

TABLE 530            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)         351

TABLE 531            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION)            352

TABLE 532            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                352

TABLE 533            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          352

TABLE 534            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023–2030 (USD MILLION)            353

TABLE 535            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET,

BY END USER, 2023–2030 (USD MILLION)               353

TABLE 536            GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET,

BY PRODUCT, 2023–2030 (USD MILLION)               354

TABLE 537            GCC COUNTRIES: LATERAL FLOW READERS MARKET,

BY TYPE, 2023–2030 (USD MILLION)         354

TABLE 538            GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       355

TABLE 539            GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY TYPE, 2023–2030 (USD MILLION)         355

TABLE 540            GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2023–2030 (USD MILLION)            356

TABLE 541            GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2023–2030 (USD MILLION)            356

TABLE 542            GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2023–2030 (USD MILLION) 357

TABLE 543            GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY &

FERTILITY TESTING, BY TYPE, 2023–2030 (USD MILLION)                 357

TABLE 544            GCC COUNTRIES: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE, 2023–2030 (USD MILLION)          357

TABLE 545            GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING,

BY SAMPLE TYPE, 2023–2030 (USD MILLION)       358

TABLE 546            GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET,

BY END USER, 2023–2030 (USD MILLION)               358

TABLE 547            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATERAL

FLOW ASSAYS MARKET 360

TABLE 548            LATERAL FLOW ASSAYS MARKET: DEGREE OF COMPETITION 363

TABLE 549            LATERAL FLOW ASSAYS MARKET: REGIONAL FOOTPRINT, 2024             369

TABLE 550            LATERAL FLOW ASSAYS MARKET: PRODUCT FOOTPRINT, 2024             370

TABLE 551            LATERAL FLOW ASSAYS MARKET: TECHNIQUE FOOTPRINT. 2024             371

TABLE 552            LATERAL FLOW ASSAYS MARKET: APPLICATION FOOTPRINT, 2024             372

TABLE 553            LATERAL FLOW ASSAYS MARKET: SAMPLE TYPE FOOTPRINT, 2024             373

TABLE 554            LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF KEY STARTUP/SME

PLAYERS, 2024   375

TABLE 555            LATERAL FLOW ASSAYS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024                 375

TABLE 556            LATERAL FLOW ASSAYS MARKET: PRODUCT LAUNCHES,

JANUARY 2021–MAY 2025               376

TABLE 557            LATERAL FLOW ASSAYS MARKET: DEALS, JANUARY 2021–MAY 2025               376

TABLE 558            LATERAL FLOW ASSAYS MARKET: EXPANSIONS, JANUARY 2021–MAY 2025               377

TABLE 559            ABBOTT LABORATORIES: BUSINESS OVERVIEW                 378

TABLE 560            ABBOTT LABORATORIES: PRODUCTS OFFERED                 379

TABLE 561            ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–MAY 2025               383

TABLE 562            F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW          384

TABLE 563            F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED             385

TABLE 564            DANAHER CORPORATION: COMPANY OVERVIEW          387

TABLE 565            DANAHER CORPORATION: PRODUCTS OFFERED             388

TABLE 566            QUIDELORTHOORTHO CORPORATION: COMPANY OVERVIEW   390

TABLE 567            QUIDELORTHOORTHO CORPORATION: PRODUCTS OFFERED    391

TABLE 568            QUIDELORTHOORTHO CORPORATION: DEALS                 392

TABLE 569            SIEMENS AG: COMPANY OVERVIEW        393

TABLE 570            SIEMENS AG: PRODUCTS OFFERED         395

TABLE 571            BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW   396

TABLE 572            BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED    398

TABLE 573            BIOMÉRIEUX SA: COMPANY OVERVIEW 399

TABLE 574            BIOMÉRIEUX SA: PRODUCTS OFFERED 400

TABLE 575            BIOMÉRIEUX SA: DEALS                401

TABLE 576            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          402

TABLE 577            THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED             403

TABLE 578            REVVITY, INC.: COMPANY OVERVIEW    405

TABLE 579            REVVITY, INC.: PRODUCTS OFFERED     406

TABLE 580            QIAGEN N.V.: COMPANY OVERVIEW       407

TABLE 581            QIAGEN N.V.: PRODUCTS OFFERED        408

TABLE 582            MERCK KGAA: COMPANY OVERVIEW     409

TABLE 583            MERCK KGAA: PRODUCTS OFFERED      410

TABLE 584            MERCK KGAA: EXPANSIONS        410

TABLE 585            HOLOGIC, INC.: COMPANY OVERVIEW  411

TABLE 586            HOLOGIC, INC.: PRODUCTS OFFERED   412

TABLE 587            HOLOGIC, INC.: DEALS 413

TABLE 588            SURMODICS, INC.: COMPANY OVERVIEW                 414

TABLE 589            SURMODICS, INC.: PRODUCTS OFFERED                 416

TABLE 590            SURMODICS, INC.: DEALS             416

TABLE 591            ORASURE TECHNOLOGIES: COMPANY OVERVIEW          417

TABLE 592            ORASURE TECHNOLOGIES: PRODUCTS OFFERED             418

TABLE 593            CHEMBIO DIAGNOSTICS INC.: COMPANY OVERVIEW          419

TABLE 594            DCN DIAGNOSTICS: COMPANY OVERVIEW                 420

TABLE 595            POLYSCIENCES INC.: COMPANY OVERVIEW                 421

TABLE 596            ABINGDON HEALTH: COMPANY OVERVIEW                 422

TABLE 597            ORANOXIS INC.: COMPANY OVERVIEW 423

TABLE 598            AESKU.GROUP GMBH: COMPANY OVERVIEW                 424

TABLE 599            BIO GROUP MEDICAL SYSTEM S.R.L: COMPANY OVERVIEW          425

TABLE 600            PHARMACT GMBH: COMPANY OVERVIEW                 426

TABLE 601            XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW   427

TABLE 602            BIOPANDA REAGENTS LTD: COMPANY OVERVIEW          428

TABLE 603            ARTRON LABORATORIES INC.: COMPANY OVERVIEW          429

LIST OF FIGURES

FIGURE 1              LATERAL FLOW ASSAYS: MARKET SEGMENTATION              43

FIGURE 2              STUDY YEARS CONSIDERED       44

FIGURE 3              LATERAL FLOW ASSAYS MARKET: RESEARCH DESIGN                46

FIGURE 4              KEY DATA FROM SECONDARY SOURCES                 47

FIGURE 5              LIST OF PRIMARY SOURCES        48

FIGURE 6              KEY INSIGHTS FROM INDUSTRY EXPERTS                 49

FIGURE 7              BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE,

DESIGNATION, AND REGION     50

FIGURE 8              BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH              52

FIGURE 9              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 53

FIGURE 10            LATERAL FLOW ASSAYS MARKET: TOP-DOWN APPROACH         53

FIGURE 11            DATA TRIANGULATION METHODOLOGY                 54

FIGURE 12            LATERAL FLOW ASSAYS MARKET: ASSUMPTION IMPACT ASSESSMENT   55

FIGURE 13            LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2025 VS. 2030 (USD BILLION)       57

FIGURE 14            LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)       58

FIGURE 15            LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,

2025 VS. 2030 (USD MILLION)      58

FIGURE 16            LATERAL FLOW ASSAY MARKET, BY SAMPLE TYPE, 2025 VS. 2030 (USD MILLION)         59

FIGURE 17            LATERAL FLOW ASSAYS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      59

FIGURE 18            GEOGRAPHICAL SNAPSHOT OF LATERAL FLOW ASSAYS MARKET               60

FIGURE 19            HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET         62

FIGURE 20            CLINICAL TESTING APPLICATION AND CHINA LED ASIA PACIFIC MARKET IN 2024          63

FIGURE 21            CHINA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030          64

FIGURE 22            ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD       64

FIGURE 23            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING

FORECAST PERIOD         65

FIGURE 24            LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          66

FIGURE 25            LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 74

FIGURE 26            LATERAL FLOW ASSAYS MARKET: PATENT ANALYSIS,

JANUARY 2015–DECEMBER 2024 81

FIGURE 27            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS

FOR TOP THREE APPLICATIONS               87

FIGURE 28            KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 88

FIGURE 29            VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING

AND ASSEMBLY PHASES                89

FIGURE 30            LATERAL FLOW ASSAYS MARKET: SUPPLY CHAIN ANALYSIS              90

FIGURE 31            AI USE CASES     92

FIGURE 32            LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS            93

FIGURE 33            ADJACENT MARKETS FOR LATERAL FLOW ASSAYS MARKET               96

FIGURE 34            LATERAL FLOW ASSAYS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS            96

FIGURE 35            LATERAL FLOW ASSAYS MARKET: INVESTMENT AND

FUNDING SCENARIO, 2020–2024 97

FIGURE 36            NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT       239

FIGURE 37            ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT          289

FIGURE 38            REVENUE ANALYSIS OF KEY PLAYERS IN LATERAL FLOW ASSAYS

MARKET, 2020–2024          361

FIGURE 39            MARKET SHARE ANALYSIS OF KEY PLAYERS IN LATERAL

FLOW ASSAYS MARKET, 2024       362

FIGURE 40            EV/EBITDA OF KEY VENDORS, 2025         364

FIGURE 41            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS, 2025 364

FIGURE 42            LATERAL FLOW ASSAYS MARKET: BRAND/PRODUCT COMPARISON             365

FIGURE 43            LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       367

FIGURE 44            LATERAL FLOW ASSAYS MARKET: COMPANY FOOTPRINT, 2024             368

FIGURE 45            LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 374

FIGURE 46            ABBOTT LABORATORIES: COMPANY SNAPSHOT, 2024               379

FIGURE 47            F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT, 2024               385

FIGURE 48            DANAHER CORPORATION: COMPANY SNAPSHOT, 2024               388

FIGURE 49            QUIDELORTHOORTHO CORPORATION: COMPANY SNAPSHOT, 2024         391

FIGURE 50            SIEMENS AG: COMPANY SNAPSHOT, 2024                 394

FIGURE 51            BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT, 2024         397

FIGURE 52            BIOMÉRIEUX SA: COMPANY SNAPSHOT, 2024                 400

FIGURE 53            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT, 2024               403

FIGURE 54            REVVITY, INC.: COMPANY SNAPSHOT, 2024                 405

FIGURE 55            QIAGEN N.V.: COMPANY SNAPSHOT, 2024                 408

FIGURE 56            MERCK KGAA: COMPANY SNAPSHOT, 2024                 409

FIGURE 57            HOLOGIC, INC.: COMPANY SNAPSHOT, 2024                 412

FIGURE 58            SURMODICS, INC.: COMPANY SNAPSHOT, 2024                 415

FIGURE 59            ORASURE TECHNOLOGIES: COMPANY SNAPSHOT, 2024               417

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧